Cargando…

Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol

INTRODUCTION: As patient assessment of health-related quality of life (HRQOL) in cancer clinical trials has increased over the years, so has the need to attach meaningful interpretations to differences in HRQOL scores between groups and changes within groups. Determining what represents a minimally...

Descripción completa

Detalles Bibliográficos
Autores principales: Musoro, Zebedee Jammbe, Hamel, Jean-Francois, Ediebah, Divine Ewane, Cocks, Kim, King, Madeleine T, Groenvold, Mogens, Sprangers, Mirjam A G, Brandberg, Yvonne, Velikova, Galina, Maringwa, John, Flechtner, Hans-Henning, Bottomley, Andrew, Coens, Corneel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781104/
https://www.ncbi.nlm.nih.gov/pubmed/29326191
http://dx.doi.org/10.1136/bmjopen-2017-019117
_version_ 1783294880199475200
author Musoro, Zebedee Jammbe
Hamel, Jean-Francois
Ediebah, Divine Ewane
Cocks, Kim
King, Madeleine T
Groenvold, Mogens
Sprangers, Mirjam A G
Brandberg, Yvonne
Velikova, Galina
Maringwa, John
Flechtner, Hans-Henning
Bottomley, Andrew
Coens, Corneel
author_facet Musoro, Zebedee Jammbe
Hamel, Jean-Francois
Ediebah, Divine Ewane
Cocks, Kim
King, Madeleine T
Groenvold, Mogens
Sprangers, Mirjam A G
Brandberg, Yvonne
Velikova, Galina
Maringwa, John
Flechtner, Hans-Henning
Bottomley, Andrew
Coens, Corneel
author_sort Musoro, Zebedee Jammbe
collection PubMed
description INTRODUCTION: As patient assessment of health-related quality of life (HRQOL) in cancer clinical trials has increased over the years, so has the need to attach meaningful interpretations to differences in HRQOL scores between groups and changes within groups. Determining what represents a minimally important difference (MID) in HRQOL scores is useful to clinicians, patients and researchers, and can be used as a benchmark for assessing the success of a healthcare intervention. Our objective is to provide an evidence-based protocol to determine MIDs for the European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 (EORTC QLQ-C30). We will mainly focus on MID estimation for group-level comparisons. Responder thresholds for individual-level change will also be estimated. METHODS AND ANALYSIS: Data will be derived from published phase II and III EORTC trials that used the QLQ-C30 instrument, covering several cancer sites. We will use individual patient data to estimate MIDs for different cancer sites separately. Focus is on anchor-based methods. Anchors will be selected per disease site from available data. A disease-oriented and methodological panel will provide independent guidance on anchor selection. We aim to construct multiple clinical anchors per QLQ-C30 scale and also to compare with several anchor-based methods. The effects of covariates, for example, gender, age, disease stage and so on, will also be investigated. We will examine how our estimated MIDs compare with previously published guidelines, hence further contributing to robust MID guidelines for the EORTC QLQ-C30. ETHICS AND DISSEMINATION: All patient data originate from completed clinical trials with mandatory written informed consent, approved by local ethical committees. Our findings will be presented at scientific conferences, disseminated via peer-reviewed publications and also compiled in a MID ‘blue book’ which will be made available online on the EORTC Quality of Life Group website as a free guideline document.
format Online
Article
Text
id pubmed-5781104
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57811042018-01-31 Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol Musoro, Zebedee Jammbe Hamel, Jean-Francois Ediebah, Divine Ewane Cocks, Kim King, Madeleine T Groenvold, Mogens Sprangers, Mirjam A G Brandberg, Yvonne Velikova, Galina Maringwa, John Flechtner, Hans-Henning Bottomley, Andrew Coens, Corneel BMJ Open Oncology INTRODUCTION: As patient assessment of health-related quality of life (HRQOL) in cancer clinical trials has increased over the years, so has the need to attach meaningful interpretations to differences in HRQOL scores between groups and changes within groups. Determining what represents a minimally important difference (MID) in HRQOL scores is useful to clinicians, patients and researchers, and can be used as a benchmark for assessing the success of a healthcare intervention. Our objective is to provide an evidence-based protocol to determine MIDs for the European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 (EORTC QLQ-C30). We will mainly focus on MID estimation for group-level comparisons. Responder thresholds for individual-level change will also be estimated. METHODS AND ANALYSIS: Data will be derived from published phase II and III EORTC trials that used the QLQ-C30 instrument, covering several cancer sites. We will use individual patient data to estimate MIDs for different cancer sites separately. Focus is on anchor-based methods. Anchors will be selected per disease site from available data. A disease-oriented and methodological panel will provide independent guidance on anchor selection. We aim to construct multiple clinical anchors per QLQ-C30 scale and also to compare with several anchor-based methods. The effects of covariates, for example, gender, age, disease stage and so on, will also be investigated. We will examine how our estimated MIDs compare with previously published guidelines, hence further contributing to robust MID guidelines for the EORTC QLQ-C30. ETHICS AND DISSEMINATION: All patient data originate from completed clinical trials with mandatory written informed consent, approved by local ethical committees. Our findings will be presented at scientific conferences, disseminated via peer-reviewed publications and also compiled in a MID ‘blue book’ which will be made available online on the EORTC Quality of Life Group website as a free guideline document. BMJ Publishing Group 2018-01-10 /pmc/articles/PMC5781104/ /pubmed/29326191 http://dx.doi.org/10.1136/bmjopen-2017-019117 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Oncology
Musoro, Zebedee Jammbe
Hamel, Jean-Francois
Ediebah, Divine Ewane
Cocks, Kim
King, Madeleine T
Groenvold, Mogens
Sprangers, Mirjam A G
Brandberg, Yvonne
Velikova, Galina
Maringwa, John
Flechtner, Hans-Henning
Bottomley, Andrew
Coens, Corneel
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
title Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
title_full Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
title_fullStr Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
title_full_unstemmed Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
title_short Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
title_sort establishing anchor-based minimally important differences (mid) with the eortc quality-of-life measures: a meta-analysis protocol
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781104/
https://www.ncbi.nlm.nih.gov/pubmed/29326191
http://dx.doi.org/10.1136/bmjopen-2017-019117
work_keys_str_mv AT musorozebedeejammbe establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT hameljeanfrancois establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT ediebahdivineewane establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT cockskim establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT kingmadeleinet establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT groenvoldmogens establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT sprangersmirjamag establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT brandbergyvonne establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT velikovagalina establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT maringwajohn establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT flechtnerhanshenning establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT bottomleyandrew establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol
AT coenscorneel establishinganchorbasedminimallyimportantdifferencesmidwiththeeortcqualityoflifemeasuresametaanalysisprotocol